137 related articles for article (PubMed ID: 35766123)
1. Engineered exoASO-STAT6: a potent monotherapy for oral squamous cell carcinoma.
Jayaseelan VP; Paramasivam A
Future Oncol; 2022 Aug; 18(25):2767-2769. PubMed ID: 35766123
[No Abstract] [Full Text] [Related]
2. Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity.
Kamerkar S; Leng C; Burenkova O; Jang SC; McCoy C; Zhang K; Dooley K; Kasera S; Zi T; Sisó S; Dahlberg W; Sia CL; Patel S; Schmidt K; Economides K; Soos T; Burzyn D; Sathyanarayanan S
Sci Adv; 2022 Feb; 8(7):eabj7002. PubMed ID: 35179953
[TBL] [Abstract][Full Text] [Related]
3. Considerations regarding the tumor-suppressor role of naringenin as a novel agent for the treatment of oral squamous cell carcinoma.
Li CX; Gong ZC; Tan XR
Cancer Immunol Immunother; 2023 Sep; 72(9):3133-3134. PubMed ID: 37149552
[No Abstract] [Full Text] [Related]
4. Marine bioactive compounds as potential therapeutic inhibitor for oral squamous cell carcinoma (OSCC).
Sivaperumal P; Sekaran S; Kamala K; Ganapathy D
Oral Oncol; 2022 Aug; 131():105971. PubMed ID: 35716647
[No Abstract] [Full Text] [Related]
5. MicroRNA-138 and its targets: A therapeutic molecule for oral squamous cell carcinoma.
Selvakumar SC; K Auxzilia P; Dinesh Y; Senthilmurugan M; Sekar D
Oral Oncol; 2022 Jul; 130():105925. PubMed ID: 35606273
[No Abstract] [Full Text] [Related]
6. Emerging functions and applications of exosomes in oral squamous cell carcinoma.
Qie Y; Sun X; Yang Y; Yan T
J Oral Pathol Med; 2023 Nov; 52(10):886-894. PubMed ID: 37701945
[TBL] [Abstract][Full Text] [Related]
7. Chronotherapeutics in the management of oral squamous cell carcinoma - A futuristic novel treatment strategy.
Poornachitra P; Muthukrishnan A; Devaraj E
Indian J Cancer; 2023 Oct; 60(4):595-596. PubMed ID: 38185867
[No Abstract] [Full Text] [Related]
8. Engineered Dex: A promising therapeutic strategy for oral squamous cell carcinoma.
Vijayashree Priyadharsini J; Abilasha R; Anitha P; Paramasivam A
J Stomatol Oral Maxillofac Surg; 2023 Feb; 124(1):101277. PubMed ID: 36058533
[No Abstract] [Full Text] [Related]
9. Squamous cell carcinomas of the tongue and oral cavity as secondary malignancies: what factors are implicated?
Muggia F
Oncologist; 2013; 18(3):245-7. PubMed ID: 23485623
[TBL] [Abstract][Full Text] [Related]
10. The Roles of Exosomes in the Diagnose, Development and Therapeutic Resistance of Oral Squamous Cell Carcinoma.
Shi S; Yu ZL; Jia J
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768288
[TBL] [Abstract][Full Text] [Related]
11. Novel therapeutic inhibitors for oral squamous cell cancer (OSCC) from seaweeds.
Kannan K; Pitchiah S; E D; Ramasamy P
Eur J Surg Oncol; 2023 May; 49(5):1048-1049. PubMed ID: 36702714
[No Abstract] [Full Text] [Related]
12. Mitophagy: A therapeutic target for oral squamous cell carcinoma.
Balachander K; Paramasivam A
Oral Oncol; 2022 Jun; 129():105881. PubMed ID: 35504127
[No Abstract] [Full Text] [Related]
13. Novel HSP90 inhibitor NVP-AUY922 enhances the anti-tumor effect of temsirolimus against oral squamous cell carcinoma.
Okui T; Shimo T; Fukazawa T; Mohammad Monsur Hassan N; Honami T; Ibaragi S; Takaoka M; Naomoto Y; Sasaki A
Curr Cancer Drug Targets; 2013 Mar; 13(3):289-99. PubMed ID: 23016912
[TBL] [Abstract][Full Text] [Related]
14. Engineered therapeutic bacteria for the treatment of oral squamous cell carcinoma.
Jayaseelan VP; A S SG; Arumugam P
Oral Oncol; 2022 Jul; 130():105874. PubMed ID: 35533508
[No Abstract] [Full Text] [Related]
15. Phototoxicity of Liposomal Zn- and Al-phthalocyanine Against Cervical and Oral Squamous Cell Carcinoma Cells In Vitro.
Young J; Yee M; Kim H; Cheung J; Chino T; Düzgüneş N; Konopka K
Med Sci Monit Basic Res; 2016 Dec; 22():156-164. PubMed ID: 27932777
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of Akt by methanol extracts of Impatiens balsamina L. promotes apoptosis in human oral squamous cell carcinoma cell lines.
Shin JA; Ryu MH; Kwon KH; Choi B; Cho SD
J Oral Pathol Med; 2015 Jul; 44(6):420-8. PubMed ID: 25212570
[TBL] [Abstract][Full Text] [Related]
17. Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophage polarization mediated by exosome-enclosed miR-29a-3p.
Cai J; Qiao B; Gao N; Lin N; He W
Am J Physiol Cell Physiol; 2019 May; 316(5):C731-C740. PubMed ID: 30811223
[TBL] [Abstract][Full Text] [Related]
18. Paraoxonase-2 expression in oral squamous cell carcinoma.
Campagna R; Pozzi V; Salvucci A; Togni L; Mascitti M; Sartini D; Salvolini E; Santarelli A; Lo Muzio L; Emanuelli M
Hum Cell; 2023 May; 36(3):1211-1213. PubMed ID: 36774414
[No Abstract] [Full Text] [Related]
19. Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression.
Prgomet Z; Axelsson L; Lindberg P; Andersson T
J Oral Pathol Med; 2015 Nov; 44(10):776-84. PubMed ID: 25459554
[TBL] [Abstract][Full Text] [Related]
20. The scorpion venom peptide BmKn2 induces apoptosis in cancerous but not in normal human oral cells.
Satitmanwiwat S; Changsangfa C; Khanuengthong A; Promthep K; Roytrakul S; Arpornsuwan T; Saikhun K; Sritanaudomchai H
Biomed Pharmacother; 2016 Dec; 84():1042-1050. PubMed ID: 27780132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
